EyePoint Pharmaceuticals
EYPT
#5227
Rank
S$1.91 B
Marketcap
S$23.11
Share price
0.45%
Change (1 day)
94.69%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Total assets

Total assets on the balance sheet as of September 2025 : S$0.32 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's total assets are S$0.32 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

EyePoint Pharmaceuticals - Total assets on balance sheet (from 2003 to 2025)

Total assets by year

Year Total assets Change
2024-12-31S$0.56 B21.26%
2023-12-31S$0.46 B94.01%
2022-12-31S$0.24 B-32.09%
2021-12-31S$0.35 B193.45%
2020-12-31S$0.12 B23.34%
2019-12-31S$98.37 M
2018-06-30S$97.67 M279.91%
2017-06-30S$25.71 M-39.64%
2016-06-30S$42.59 M-2.33%
2015-06-30S$43.61 M54.3%
2014-06-30S$28.26 M37.07%
2013-06-30S$20.62 M-20.99%
2012-06-30S$26.09 M-54.86%
2011-06-30S$57.81 M-3.2%
2010-06-30S$59.72 M11.44%
2009-06-30S$53.59 M-29.4%
2008-06-30S$75.91 M-51.72%
2007-06-30S$0.15 B-43.5%
2006-06-30S$0.27 B135.59%
2005-06-30S$0.11 B145.65%
2004-06-30S$48.08 M468.15%
2003-06-30S$8.46 M
2001-06-30S$8.6 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NRC Health
NRC
S$0.17 B-46.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
S$0.35 M-99.89% Bahamas